{
  "member": {
    "name": "Rohan Patel",
    "age": 46,
    "location": "Singapore",
    "profession": "Senior Finance Executive",
    "baseline": {
      "bloodPressure": "136/88 mmHg",
      "restingHR": "58 bpm",
      "HRV": "42 ms"
    }
  },
  "episodes": [
    {
      "id": "E01",
      "title": "Establishing the Baseline",
      "weeks": "1-4",
      "granularEvents": [
        {
          "eventId": "E01-01",
          "week": 1,
          "title": "Initial consult scheduling",
          "description": "Ruby coordinates initial consults with Dr. Warren, Carla and Rachel.",
          "sourceCommunication": "Ruby (Elyx): \"Hi Sarah, hope you're having a good start to the week. I'm looking to get Rohan's initial consultations with his Elyx team (Dr. Warren, Carla, and Rachel) on the calendar...\"",
          "timestamp": "8/25/25, 9:55 AM"
        },
        {
          "eventId": "E01-02",
          "week": 1,
          "title": "Whoop/Garmin data access requested",
          "description": "Rohan asks who needs access and requests data privacy/security protocols.",
          "sourceCommunication": "Rohan Patel: \"Ruby, Sarah is handling the scheduling. While she does that, who needs access to my Whoop and Garmin data? Also, please send over your data privacy and security protocols.\"",
          "timestamp": "8/25/25, 11:28 AM"
        },
        {
          "eventId": "E01-03",
          "week": 1,
          "title": "Wearable sync confirmed",
          "description": "Advik confirms wearable sync and initial pattern detection for HRV / sleep.",
          "sourceCommunication": "Advik (Elyx): \"Advik: Data sync is successful. I'm already seeing some interesting patterns in your HRV and sleep data over the last month. We'll use this as our starting point for our experiments.\"",
          "timestamp": "8/25/25, 12:08 PM"
        },
        {
          "eventId": "E01-04",
          "week": 1,
          "title": "Baseline consult confirmed by Dr. Warren",
          "description": "Dr. Warren confirms the initial consultation and intention to establish a clinical baseline.",
          "sourceCommunication": "Dr. Warren: \"Dr. Warren: Rohan, Dr. Warren. I see our initial consultation is confirmed. I look forward to reviewing your medical history and establishing a precise clinical baseline to target your cardiovascular and cognitive health goals.\"",
          "timestamp": "8/25/25, 3:19 PM"
        },
        {
          "eventId": "E01-05",
          "week": 1,
          "title": "Anticipatory stress hypothesis surfaced",
          "description": "Advik describes consistent 15-20% dip in overnight HRV before travel\u2014a first hypothesis.",
          "sourceCommunication": "Advik (Elyx): \"Advik: Of course, Rohan. The most immediate pattern is a consistent 15-20% dip in your overnight HRV on nights preceding international travel, based on your calendar. This is our first hypothesis: a measurable anticipatory stress response.\"",
          "timestamp": "8/25/25, 4:17 PM"
        },
        {
          "eventId": "E01-06",
          "week": 1,
          "title": "London is flagged as a stress-test",
          "description": "Team and member note that the upcoming London trip will be an important real-world stress test to validate the baseline.",
          "sourceCommunication": "Ruby / Team messages around 8/25: scheduling and travel notes; (explicit London travel discussion appears in subsequent threads referencing travel as the first real stress test).",
          "timestamp": "8/25/25 \u2013 travel thread"
        }
      ]
    },
    {
      "id": "E02",
      "title": "The First Experiment & Clinical Baseline",
      "weeks": "5-9",
      "granularEvents": [
        {
          "eventId": "E02-01",
          "week": 2,
          "title": "Sleep consistency emphasized",
          "description": "Team emphasizes sleep as the primary lever for week-to-week improvements.",
          "sourceCommunication": "Carla / Team messages (8/26\u20138/29): guidance sent on sleep hygiene and consistency as the first high-priority habit.",
          "timestamp": "8/26/25 \u2013 8/29/25"
        },
        {
          "eventId": "E02-02",
          "week": 2,
          "title": "Early improvements recorded",
          "description": "Logs show early improvements in sleep adherence (e.g., 75% \u2192 82% in this phase).",
          "sourceCommunication": "Nutrition / wearable notes in chat referencing better sleep consistency and early positive signals in HRV/BP.",
          "timestamp": "late Aug 2025"
        },
        {
          "eventId": "E02-03",
          "week": 2,
          "title": "No major friction recorded",
          "description": "Team notes this period had smooth execution\u2014no reported scheduling or adherence incidents.",
          "sourceCommunication": "Chat threads indicate no major friction logged for the period; focus on steady baseline work.",
          "timestamp": "Aug 26\u2013Sep 1, 2025"
        }
      ]
    },
    {
      "id": "E03",
      "title": "Decoding the Data, Refining the Strategy",
      "weeks": "10-14",
      "granularEvents": [
        {
          "eventId": "E03-01",
          "week": 3,
          "title": "Comprehensive panel ordered",
          "description": "Dr. Warren orders the diagnostic panel to establish labs including ApoB and hs-CRP.",
          "sourceCommunication": "Dr. Warren (chat): \"Panel to establish clinical baseline; monitor hs-CRP correlation.\"",
          "timestamp": "8/27/25"
        },
        {
          "eventId": "E03-02",
          "week": 3,
          "title": "ApoB elevated and flagged",
          "description": "Initial labs show elevated ApoB; team flags it as a primary actionable risk factor.",
          "sourceCommunication": "Dr. Warren (8/28): \"ApoB decreased to 98 mg/dL; goal <80 mg/dL.\" and earlier notes of elevated ApoB in the baseline reading.",
          "timestamp": "8/28/25"
        },
        {
          "eventId": "E03-03",
          "week": 3,
          "title": "Dinner experiment proposed",
          "description": "Team proposes testing late-night meal composition (protein/veg + limited alcohol) to see if HRV suppression is mitigated.",
          "sourceCommunication": "Advik (8/29): \"Late dinner experiment: prioritize protein/veg; cap alcohol; expect ~50% reduction in HRV suppression.\"",
          "timestamp": "8/29/25"
        },
        {
          "eventId": "E03-04",
          "week": 3,
          "title": "Zone 2 volume increase",
          "description": "Team recommends increasing Zone 2 cardio volume to improve mitochondrial health and cardiovascular efficiency.",
          "sourceCommunication": "Advik / planning messages referencing increasing cardio minutes and zone guidance.",
          "timestamp": "late Aug 2025"
        },
        {
          "eventId": "E03-05",
          "week": 3,
          "title": "Plant sterol / nutrition intervention",
          "description": "Carla reduces saturated fat target and adds plant sterols / soluble fiber to target ApoB.",
          "sourceCommunication": "Carla (8/28): \"Reduced saturated fat to <7% kcal; specific food swaps planned. Added 2 g/d plant sterols targeting 10\u201315% LDL-C lowering.\"",
          "timestamp": "8/28/25"
        }
      ]
    },
    {
      "id": "E04",
      "title": "Mastering Travel & Expanding Horizons",
      "weeks": "15-20",
      "granularEvents": [
        {
          "eventId": "E04-01",
          "week": 4,
          "title": "Singapore travel stress-check",
          "description": "Trip to Singapore used to stress-test resilience; team notes performance near baseline.",
          "sourceCommunication": "Travel notes and wearable summaries show Rohan maintained HRV/RHR near baseline during Singapore travel.",
          "timestamp": "late Aug / early Sep 2025"
        },
        {
          "eventId": "E04-02",
          "week": 4,
          "title": "Workout schedule failure identified",
          "description": "Rohan reports a 60% failure rate for post-5pm workouts; frames the problem as a system design issue.",
          "sourceCommunication": "Rohan (8/31): \"Reported 60% failure rate for after-5pm workouts; requested creative model.\"",
          "timestamp": "8/31/25"
        },
        {
          "eventId": "E04-03",
          "week": 4,
          "title": "System redesign principle set",
          "description": "Neel/strategist recommends anchoring plans around physiological readiness (HRV/sleep) rather than calendar convenience.",
          "sourceCommunication": "Neel (8/31): \"Anchor plan to protect physiological readiness (HRV/sleep), not just session completion.\"",
          "timestamp": "8/31/25"
        },
        {
          "eventId": "E04-04",
          "week": 4,
          "title": "Golf performance goal introduced",
          "description": "Rohan expresses interest in sport-specific optimization (golf), prompting a dedicated block for rotational power and mobility.",
          "sourceCommunication": "Rohan/team messages indicating new performance goal: golf training.",
          "timestamp": "early Sep 2025"
        }
      ]
    },
    {
      "id": "E05",
      "title": "System Failure, Clinical Success",
      "weeks": "21-26",
      "granularEvents": [
        {
          "eventId": "E05-01",
          "week": 5,
          "title": "Quarterly diagnostics: major improvements",
          "description": "Quarterly labs reveal large reductions in ApoB and hs-CRP; team celebrates clinical wins.",
          "sourceCommunication": "Dr. Warren (9/02): \"Baseline ApoB 115 \u2192 82 mg/dL; baseline hs-CRP 2.8 \u2192 0.9 mg/L.\"",
          "timestamp": "9/02/25"
        },
        {
          "eventId": "E05-02",
          "week": 5,
          "title": "ASCVD risk updated",
          "description": "Team reports large relative reduction in 10-year ASCVD risk after interventions.",
          "sourceCommunication": "Dr. Warren (9/02): \"Estimated 45.6% relative reduction in 10-yr ASCVD risk; risk class moved from Intermediate to Borderline.\"",
          "timestamp": "9/02/25"
        },
        {
          "eventId": "E05-03",
          "week": 5,
          "title": "Acute illness detected via wearable",
          "description": "Whoop/wearable detection shows HRV drop and RHR rise; team pivots to sick-day protocol and rest.",
          "sourceCommunication": "Advik/Rachel messages (early Sep 2025): \"HRV dropped ~15 ms; RHR up ~8 bpm \u2014 classic immune response pattern.\" & 'Swapped strength for light mobility/breathing; rest prioritized.'",
          "timestamp": "9/01/25"
        },
        {
          "eventId": "E05-04",
          "week": 5,
          "title": "Adaptive recovery protocol executed",
          "description": "Elyx activates sick-day measures including rest, IV + supportive care coordination (documented in logs previously).",
          "sourceCommunication": "Team: sick day protocol activation messages and logistics to support rapid recovery (IV/fluids/monitoring).",
          "timestamp": "early Sep 2025"
        }
      ]
    },
    {
      "id": "E06",
      "title": "Achieving Resilience, Personalizing the Future",
      "weeks": "27-32",
      "granularEvents": [
        {
          "eventId": "E06-01",
          "week": 6,
          "title": "Genetic testing ordered",
          "description": "Dr. Warren authorizes ApoE and MTHFR testing to enable hyper-personalized next-phase interventions.",
          "sourceCommunication": "Dr. Warren (9/02): \"Authorized genetic panel for ApoE and MTHFR.\"",
          "timestamp": "9/02/25"
        },
        {
          "eventId": "E06-02",
          "week": 6,
          "title": "32-week biomarker review",
          "description": "Team presents 32-week report showing major risk reductions and recommends next-phase personalization.",
          "sourceCommunication": "Summary messages (9/02): \"32-week report shows ~45.6% relative reduction in 10-yr ASCVD risk; ApoB and hs-CRP down substantially.\"",
          "timestamp": "9/02/25"
        },
        {
          "eventId": "E06-03",
          "week": 6,
          "title": "Travel resilience confirmed",
          "description": "Whoop/wearable data shows recovery & HRV volatility improvements compared to early travel\u2014team marks this as resilience achieved.",
          "sourceCommunication": "Wearable summary lines: travel recovery metrics improved (HRV volatility down ~40%, Recovery ~88%).",
          "timestamp": "late Aug\u2013early Sep 2025"
        }
      ]
    }
  ]
}